Rafferty Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36,050	Closed	-$664K	–	1135
2025 Q3	$664K	Sell	36,050 -1,596	-4%	-$25.6K	﹤0.01%	858
2025 Q2	$490K	Sell	37,646 -11,837	-24%	-$140K	﹤0.01%	895
2025 Q1	$524K	Sell	49,483 -8,109	-14%	-$129K	﹤0.01%	854
2024 Q4	$977K	Sell	57,592 -7,628	-12%	-$144K	﹤0.01%	798
2024 Q3	$1.51M	Sell	65,220 -12,794	-16%	-$274K	0.01%	706
2024 Q2	$1.9M	Sell	78,014 -78,579	-50%	-$2.38M	0.01%	656
2024 Q1	$5.29M	Buy	156,593 +43,421	+38%	+$1.54M	0.02%	465
2023 Q4	$3.57M	Sell	113,172 -19,609	-15%	-$466K	0.02%	514
2023 Q3	$3.39M	Sell	132,781 -25,704	-16%	-$792K	0.02%	476
2023 Q2	$4.55M	Sell	158,485 -47,989	-23%	-$1.31M	0.03%	438
2023 Q1	$4.95M	Sell	206,474 -2,780	-1%	-$49.9K	0.03%	387
2022 Q4	$3.55M	Sell	209,254 -51,726	-20%	-$902K	0.03%	451
2022 Q3	$3.87M	Buy	260,980 +60,794	+30%	+$1.02M	0.04%	377
2022 Q2	$3.15M	Sell	200,186 -102,004	-34%	-$2M	0.03%	378
2022 Q1	$8.15M	Buy	302,190 +81,784	+37%	+$2.09M	0.05%	224
2021 Q4	$8.16M	Buy	220,406 +61,523	+39%	+$2.51M	0.04%	233
2021 Q3	$7.59M	Sell	158,883 -27,946	-15%	-$1.25M	0.05%	216
2021 Q2	$6.32M	Buy	186,829 +119,483	+177%	+$4.04M	0.04%	267
2021 Q1	$2.78M	Buy	67,346 +58,551	+666%	+$3.49M	0.02%	537
2020 Q4	$382K	Sell	8,795 -42,609	-83%	-$2.89M	﹤0.01%	747
2020 Q3	$2.21M	Buy	+51,404	New	+$2.55M	0.03%	384